A comparison of medication adherence of blonanserin and aripiprazole in schizophrenic patients: a multicenter, randomized, open-label study

A comparison of medication adherence of blonanserin and aripiprazole in schizophrenic patients: a multicenter, randomized, open-label study - A-BLAS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012729

Enrollment

200

Registered

2013-12-31

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Blonanserin Aripiprazole

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Schizophrenia

Exclusion criteria

Exclusion criteria: nothing particulary

Design outcomes

Primary

Measure	Time frame
PANSS,DAI-10,CGI	—

Countries

Japan

Contacts

Public ContactHikaru Hori

University of Occupational and Environmental Health Department of Psychiatry

hori-h@med.uoeh-u.ac.jp093-691-7253

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026